Alan S. Maisel
#119,668
Most Influential Person Now
Alan S. Maisel's AcademicInfluence.com Rankings
Alan S. Maiselphilosophy Degrees
Philosophy
#5375
World Rank
#8150
Historical Rank
Logic
#2663
World Rank
#3685
Historical Rank
Download Badge
Philosophy
Alan S. Maisel's Degrees
- Doctorate Medicine University of California, San Francisco
Why Is Alan S. Maisel Influential?
(Suggest an Edit or Addition)Alan S. Maisel's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure. (2002) (2742)
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure: Analysis From Breathing Not Properly (BNP) Multinational Study (2002) (913)
- Cardio-renal syndromes: report from the consensus conference of the Acute Dialysis Quality Initiative (2009) (874)
- Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting. (2001) (816)
- State of the art: Using natriuretic peptide levels in clinical practice (2008) (780)
- Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction: Comparison With Doppler Velocity Recordings (2002) (700)
- State-of-the-Art PaperNatriuretic Peptides (2007) (694)
- A rapid bedside test for B-type peptide predicts treatment outcomes in patients admitted for decompensated heart failure: a pilot study. (2001) (681)
- Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea ☆ (2002) (606)
- B-type natriuretic peptide and renal function in the diagnosis of heart failure: an analysis from the Breathing Not Properly Multinational Study. (2003) (525)
- Bedside B-Type natriuretic peptide in the emergency diagnosis of heart failure with reduced or preserved ejection fraction. Results from the Breathing Not Properly Multinational Study. (2003) (501)
- Measurement of the interleukin family member ST2 in patients with acute dyspnea: results from the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) study. (2007) (487)
- Mid-region pro-hormone markers for diagnosis and prognosis in acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. (2010) (485)
- Utility of B-Natriuretic Peptide in Detecting Diastolic Dysfunction (2002) (453)
- Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath. (2004) (438)
- A rapid test for B-type natriuretic peptide correlates with falling wedge pressures in patients treated for decompensated heart failure: a pilot study. (2001) (438)
- Utility of B-natriuretic peptide as a rapid, point-of-care test for screening patients undergoing echocardiography to determine left ventricular dysfunction. (2001) (406)
- 2-Hour accelerated diagnostic protocol to assess patients with chest pain symptoms using contemporary troponins as the only biomarker: the ADAPT trial. (2012) (390)
- B-type natriuretic peptide predicts future cardiac events in patients presenting to the emergency department with dyspnea. (2002) (387)
- BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. (2004) (376)
- Role of Biomarkers for the Prevention, Assessment, and Management of Heart Failure: A Scientific Statement From the American Heart Association (2017) (367)
- Association of Change in N-Terminal Pro-B-Type Natriuretic Peptide Following Initiation of Sacubitril-Valsartan Treatment With Cardiac Structure and Function in Patients With Heart Failure With Reduced Ejection Fraction. (2019) (357)
- Clinical applications of B-type natriuretic peptide (BNP) testing. (2003) (355)
- Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations (2019) (335)
- How obesity affects the cut-points for B-type natriuretic peptide in the diagnosis of acute heart failure. Results from the Breathing Not Properly Multinational Study. (2006) (276)
- Evidence for functional heterogeneity of circulating B-type natriuretic peptide. (2007) (270)
- Prognostic utility of plasma neutrophil gelatinase-associated lipocalin in patients with acute heart failure: The NGAL EvaLuation Along with B-type NaTriuretic Peptide in acutely decompensated heart failure (GALLANT) trial (2011) (248)
- Uncovering heart failure in patients with a history of pulmonary disease: rationale for the early use of B-type natriuretic peptide in the emergency department. (2003) (235)
- Utility of a rapid B-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyspnea. (2002) (213)
- B-type natriuretic peptides: a diagnostic breakthrough for clinicians. (2003) (209)
- Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction (2001) (205)
- A rapid B-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter evaluation. (2002) (204)
- Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. (2004) (199)
- Minimally elevated cardiac troponin T and elevated N-terminal pro-B-type natriuretic peptide predict mortality in older adults: results from the Rancho Bernardo Study. (2008) (193)
- Epidemiology of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (192)
- Serial sampling of ST2 predicts 90-day mortality following destabilized heart failure. (2008) (192)
- Externalization of beta-adrenergic receptors promoted by myocardial ischemia. (1985) (187)
- Ninety-minute accelerated critical pathway for chest pain evaluation. (2001) (179)
- Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults: The Rancho Bernardo Study (2011) (176)
- B-type natriuretic peptide levels: diagnostic and prognostic in congestive heart failure: what's next? (2002) (171)
- Relationship between obesity and B-type natriuretic peptide levels. (2004) (170)
- State of the Art: Newer biomarkers in heart failure (2015) (170)
- Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study. (2005) (169)
- Timing of immunoreactive B-type natriuretic peptide levels and treatment delay in acute decompensated heart failure: an ADHERE (Acute Decompensated Heart Failure National Registry) analysis. (2008) (167)
- Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). (2013) (166)
- B-type natriuretic peptide levels: a potential novel "white count" for congestive heart failure. (2001) (166)
- Beta-adrenergic receptors in lymphocyte subsets after exercise. Alterations in normal individuals and patients with congestive heart failure. (1990) (163)
- Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated Copeptin: Secondary Results From the Biomarkers in Acute Heart Failure (BACH) Study (2011) (156)
- Serial changes in high‐sensitive troponin I predict outcome in patients with decompensated heart failure (2011) (153)
- A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. (2008) (143)
- Adrenergic control of circulating lymphocyte subpopulations. Effects of congestive heart failure, dynamic exercise, and terbutaline treatment. (1990) (142)
- Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women. (2003) (141)
- Diagnostic value of B-Type natriuretic peptide and chest radiographic findings in patients with acute dyspnea. (2004) (141)
- Use of procalcitonin for the diagnosis of pneumonia in patients presenting with a chief complaint of dyspnoea: results from the BACH (Biomarkers in Acute Heart Failure) trial (2012) (140)
- Pro-B-type natriuretic peptide levels in acute decompensated heart failure. (2008) (139)
- Utility of B-type natriuretic peptide (BNP) as a screen for left ventricular dysfunction in patients with diabetes. (2003) (138)
- Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study. (2003) (130)
- B-type natriuretic peptide: a novel early blood marker of acute myocardial infarction in patients with chest pain and no ST-segment elevation. (2005) (129)
- Prognosis after extension of myocardial infarct: the role of Q wave or non-Q wave infarction. (1985) (127)
- Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function: comparison with tissue Doppler imaging recordings. (2004) (125)
- Impact of age, race, and sex on the ability of B-type natriuretic peptide to aid in the emergency diagnosis of heart failure: results from the Breathing Not Properly (BNP) multinational study (2004) (124)
- Cardiorenal syndromes: an executive summary from the consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2010) (124)
- Midregion prohormone adrenomedullin and prognosis in patients presenting with acute dyspnea: results from the BACH (Biomarkers in Acute Heart Failure) trial. (2011) (123)
- Plasma proneurotensin and incidence of diabetes, cardiovascular disease, breast cancer, and mortality. (2012) (119)
- Elevation of plasma neuropeptide Y levels in congestive heart failure. (1989) (117)
- Definition and classification of Cardio-Renal Syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (116)
- A comparison of troponin T and troponin I as predictors of cardiac events in patients undergoing chronic dialysis at a Veteran's Hospital: a pilot study. (1999) (112)
- Galectin‐3 in heart failure with preserved ejection fraction (2013) (109)
- Haemodynamic-guided management of heart failure (GUIDE-HF): a randomised controlled trial (2021) (108)
- Correlation and prognostic utility of B-type natriuretic peptide and its amino-terminal fragment in patients with chronic kidney disease. (2006) (107)
- Utility of B-natriuretic peptide levels in identifying patients with left ventricular systolic or diastolic dysfunction. (2002) (107)
- Plasma adrenomedullin is associated with short-term mortality and vasopressor requirement in patients admitted with sepsis (2014) (107)
- Atrial fibrillation impairs the diagnostic performance of cardiac natriuretic peptides in dyspneic patients: results from the BACH Study (Biomarkers in ACute Heart Failure). (2013) (107)
- Implementation of novel biomarkers in the diagnosis, prognosis, and management of acute kidney injury: executive summary from the tenth consensus conference of the Acute Dialysis Quality Initiative (ADQI). (2013) (105)
- Usefulness of cardiac troponin I in patients undergoing open heart surgery. (2001) (103)
- Echocardiography and lung ultrasonography for the assessment and management of acute heart failure (2017) (103)
- Biomarkers in acute myocardial injury. (2012) (103)
- The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study. (2009) (101)
- Alterations in Skeletal Muscle Indicators of Mitochondrial Structure and Biogenesis in Patients with Type 2 Diabetes and Heart Failure: Effects of Epicatechin Rich Cocoa (2012) (100)
- Cardiac biomarkers: a contemporary status report (2006) (100)
- Diagnostic accuracy of combined cardiac troponin and copeptin assessment for early rule-out of myocardial infarction: a systematic review and meta-analysis (2014) (100)
- Post-Traumatic Stress Disorder: A Fast Track to Premature Cardiovascular Disease? (2013) (99)
- Prognostic role of B-type natriuretic peptide levels in patients with type 2 diabetes mellitus. (2004) (97)
- Primary results of the HABIT Trial (heart failure assessment with BNP in the home). (2013) (95)
- Meta-Analysis of Soluble Suppression of Tumorigenicity-2 and Prognosis in Acute Heart Failure. (2017) (94)
- Plasma neutrophil gelatinase-associated lipocalin is independently associated with cardiovascular disease and mortality in community-dwelling older adults: The Rancho Bernardo Study. (2012) (94)
- Association of ST2 levels with cardiac structure and function and mortality in outpatients. (2009) (94)
- Natriuretic Peptides in Heart Failure: Atrial and B-type Natriuretic Peptides. (2018) (92)
- Increased 90-Day Mortality in Patients With Acute Heart Failure With Elevated CopeptinClinical Perspective (2011) (92)
- Optimizing fluid management in patients with acute decompensated heart failure (ADHF): the emerging role of combined measurement of body hydration status and brain natriuretic peptide (BNP) levels (2011) (90)
- B-type natriuretic peptide and echocardiographic determination of ejection fraction in the diagnosis of congestive heart failure in patients with acute dyspnea. (2005) (88)
- Neutrophil gelatinase-associated lipocalin as a biomarker of cardiovascular disease: a systematic review (2012) (88)
- Biomarkers of renal injury and function: diagnostic, prognostic and therapeutic implications in heart failure. (2016) (87)
- B-type natriuretic peptide measurements in diagnosing congestive heart failure in the dyspneic emergency department patient. (2002) (83)
- Indications and practical approach to non-invasive ventilation in acute heart failure (2018) (83)
- (-)-Epicatechin rich cocoa mediated modulation of oxidative stress regulators in skeletal muscle of heart failure and type 2 diabetes patients. (2013) (83)
- Predictors of elevated B-type natriuretic peptide concentrations in dyspneic patients without heart failure: an analysis from the breathing not properly multinational study. (2005) (83)
- Neutrophil Gelatinase-Associated Lipocalin for Acute Kidney Injury During Acute Heart Failure Hospitalizations: The AKINESIS Study. (2016) (82)
- National Heart, Lung, and Blood Institute working group on emergency department management of acute heart failure: research challenges and opportunities. (2010) (82)
- Stability of B-type natriuretic peptide levels during exercise in patients with congestive heart failure: implications for outpatient monitoring with B-type natriuretic peptide. (2002) (81)
- A prospective study in search of an optimal B-natriuretic peptide level to screen patients for cardiac dysfunction. (2004) (79)
- Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure (2016) (79)
- MCP-1 binds to oxidized LDL and is carried by lipoprotein(a) in human plasma (2013) (78)
- Expert consensus document: Reporting checklist for quantification of pulmonary congestion by lung ultrasound in heart failure (2019) (76)
- Short-term mortality risk in emergency department acute heart failure. (2011) (76)
- B-Type Natriuretic Peptide: The Level and the Drug— Partners in the Diagnosis and Management of Congestive Heart Failure (2004) (75)
- Mitigation of the clinical significance of spurious elevations of cardiac troponin I in settings of coronary ischemia using serial testing of multiple cardiac markers. (2001) (72)
- N-terminal Pro-B-Type Natriuretic Peptide, Left Ventricular Mass, and Incident Heart Failure: Multi-Ethnic Study of Atherosclerosis (2012) (72)
- Beneficial effects of intermittent home administration of the inotrope/vasodilator milrinone in patients with end-stage congestive heart failure: a preliminary study. (1998) (72)
- A global rank end point for clinical trials in acute heart failure. (2010) (71)
- Galectin-3: A Modifiable Risk Factor in Heart Failure (2014) (71)
- Cardiovascular biomarkers and sex: the case for women (2015) (70)
- Biomarkers in acute heart failure—state of the art (2012) (69)
- S3 detection as a diagnostic and prognostic aid in emergency department patients with acute dyspnea. (2009) (69)
- B-type natriuretic peptide in the diagnosis and management of congestive heart failure. (2001) (69)
- The use of B-type natriuretic peptide to assess volume status in patients with end-stage renal disease. (2004) (69)
- Biomarkers and low risk in heart failure. Data from COACH and TRIUMPH (2015) (68)
- Gray zone BNP levels in heart failure patients in the emergency department: results from the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT) multicenter study. (2006) (67)
- Rationale and methods of the Prospective Study of Biomarkers, Symptom Improvement, and Ventricular Remodeling During Sacubitril/Valsartan Therapy for Heart Failure (PROVE‐HF) (2018) (66)
- Comparison of plasma B-type natriuretic peptide levels in single ventricle patients with systemic ventricle heart failure versus isolated cavopulmonary failure. (2006) (66)
- European Society of Cardiology-Acute Cardiovascular Care Association Position paper on acute heart failure: A call for interdisciplinary care (2017) (66)
- Beneficial effects of metoprolol treatment in congestive heart failure. Reversal of sympathetic-induced alterations of immunologic function. (1994) (66)
- Galectin-3 is independently associated with cardiovascular mortality in community-dwelling older adults without known cardiovascular disease: The Rancho Bernardo Study. (2014) (66)
- In-hospital percentage BNP reduction is highly predictive for adverse events in patients admitted for acute heart failure: the Italian RED Study (2010) (65)
- European Society of Cardiology – Acute Cardiovascular Care Association position paper on safe discharge of acute heart failure patients from the emergency department (2017) (65)
- The Diagnosis of Acute Congestive Heart Failure: Role of BNP Measurements (2003) (65)
- Utility of B-natriuretic peptide in the evaluation of left ventricular diastolic function and diastolic heart failure. (2009) (64)
- Ischemia- and agonist-induced changes in alpha- and beta-adrenergic receptor traffic in guinea pig hearts. (1987) (64)
- Soluble ST2 monitoring provides additional risk stratification for outpatients with decompensated heart failure. (2010) (63)
- The impact of B-type natriuretic peptide levels on the diagnoses and management of congestive heart failure (2002) (62)
- Proenkephalin and prognosis after acute myocardial infarction. (2014) (62)
- In vivo regulation of beta-adrenergic receptors on human mononuclear leukocytes: assessment of receptor number, location, and function after posture change, exercise, and isoproterenol infusion. (1986) (61)
- A rapid bedside test for B‐type natriuretic peptide predicts treatment outcomes in patients admitted with decompensated heart failure (2000) (60)
- Hypotension after quinidine plus verapamil. Possible additive competition at alpha-adrenergic receptors. (1985) (58)
- Use of biomarkers to assess prognosis and guide management of patients with acute kidney injury. (2013) (58)
- Diagnostic and short-term prognostic utility of plasma pro-enkephalin (pro-ENK) for acute kidney injury in patients admitted with sepsis in the emergency department (2015) (57)
- Biomarkers for Heart Failure: An Update for Practitioners of Internal Medicine. (2016) (57)
- The emerging role of biomarkers and bio-impedance in evaluating hydration status in patients with acute heart failure (2012) (55)
- Effect of spironolactone on 30-day death and heart failure rehospitalization (from the COACH Study). (2014) (55)
- Regulation of cardiac beta-adrenergic receptors by captopril. Implications for congestive heart failure. (1989) (54)
- Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major. (2010) (53)
- Cardiovascular biomarkers in acute Kawasaki disease. (2013) (53)
- Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department (2013) (52)
- Survival after hospital discharge in matched populations with inferior or anterior myocardial infarction. (1985) (51)
- Society of Chest Pain Centers Recommendations for the evaluation and management of the observation stay acute heart failure patient: a report from the Society of Chest Pain Centers Acute Heart Failure Committee. (2008) (51)
- Cardiac biomarkers: new tools for heart failure management. (2012) (51)
- Relationship of B‐type natriuretic peptide and anemia in patients with and without heart failure: A substudy from the Breathing Not Properly (BNP) Multinational Study (2005) (51)
- Breathing not properly 10 years later: what we have learned and what we still need to learn. (2012) (49)
- Biomarkers in kidney and heart disease (2011) (48)
- Influence of age, race, sex, and body mass index on interpretation of midregional pro atrial natriuretic peptide for the diagnosis of acute heart failure: results from the BACH multinational study (2012) (47)
- Role of Cardiac Troponin Levels in Acute Heart Failure. (2015) (47)
- Low-risk acute heart failure patients: external validation of the Society of Chest Pain Center's recommendations. (2009) (47)
- Serial measurement of N-terminal pro-B-type natriuretic peptide and cardiac troponin T for cardiovascular disease risk assessment in the Multi-Ethnic Study of Atherosclerosis (MESA). (2015) (46)
- Proenkephalin predicts acute kidney injury in cardiac surgery patients. (2015) (46)
- The coming of age of natriuretic peptides: the emperor does have clothes! (2006) (46)
- Diagnostic ability of B-type natriuretic peptide and impedance cardiography: testing to identify left ventricular dysfunction in hypertensive patients. (2005) (45)
- The associations between metabolic variables and NT-proBNP are blunted at pathological ranges: the Multi-Ethnic Study of Atherosclerosis. (2014) (44)
- Society of Chest Pain Centers recommendations for the evaluation and management of the observation stay acute heart failure patient—part 1 (2009) (44)
- Circulating Proneurotensin Concentrations and Cardiovascular Disease Events in the Community: The Framingham Heart Study (2016) (43)
- Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure☆ (2002) (43)
- Biomonitoring and biomarker-guided therapy: the next step in heart failure and biomarker research. (2011) (43)
- Additive diagnostic and prognostic value of Bioelectrical Impedance Vector Analysis (BIVA) to brain natriuretic peptide ‘grey-zone’ in patients with acute heart failure in the emergency department (2014) (42)
- Short-term serial sampling of natriuretic peptides in patients presenting with chest pain. (2007) (42)
- Elevated natriuretic peptide levels and cognitive function in community-dwelling older adults. (2011) (41)
- Role of biomarkers in the diagnosis and management of cardio-renal syndromes. (2012) (41)
- Differentiation of cardiac and noncardiac dyspnea using bioelectrical impedance vector analysis (BIVA). (2012) (41)
- Perturbations in skeletal muscle sarcomere structure in patients with heart failure and type 2 diabetes: restorative effects of (-)-epicatechin-rich cocoa. (2013) (41)
- Differences in Natriuretic Peptide Levels by Race/Ethnicity (From the Multi-Ethnic Study of Atherosclerosis). (2017) (41)
- Cardiac Biomarkers in the Emergency Department: The Role of Soluble ST2 (sST2) in Acute Heart Failure and Acute Coronary Syndrome—There is Meat on the Bone (2019) (40)
- Patients with acute heart failure in the emergency department: do they all need to be admitted? (2012) (40)
- Cyclic AMP counteracts mitogen‐induced inositol phosphate generation and increases in intracellular Ca2+ concentrations in human lymphocytes (1991) (40)
- Soluble CD146, a new endothelial biomarker of acutely decompensated heart failure. (2015) (39)
- Hemodynamic-GUIDEd management of Heart Failure (GUIDE-HF). (2019) (39)
- The murmur of papillary muscle dysfunction in acute myocardial infarction: clinical features and prognostic implications. (1986) (39)
- Cardiac natriuretic peptides:a proteomic window to cardiac function and clinical management. (2003) (39)
- Determinants of plasma NT-pro-BNP levels in patients with atrial fibrillation and preserved left ventricular ejection fraction (2009) (39)
- The Use of Biomarkers in the Patient with Heart Failure (2013) (39)
- The IL-33/ST2 pathway, inflammation and atherosclerosis: Trigger and target? (2018) (39)
- Practical approach on frail older patients attended for acute heart failure. (2016) (39)
- Neutrophil Gelatinase Associated Lipocalin in Acute Kidney Injury (2013) (39)
- Propranolol treatment externalizes beta-adrenergic receptors in guinea pig myocardium and prevents further externalization by ischemia. (1987) (38)
- ADQI 7: the clinical management of the Cardio-Renal syndromes: work group statements from the 7th ADQI consensus conference. (2010) (38)
- Nesiritide: a new therapy for the treatment of heart failure. (2003) (38)
- Natriuretic peptides in heart failure. (2010) (38)
- Role of biomarkers in the diagnosis and prognosis of acute kidney injury in patients with cardiorenal syndrome (2012) (38)
- Polymorphic ventricular tachycardia and other complex arrhythmias in organophosphate insecticide poisoning. (1984) (38)
- Use of natriuretic peptides in pre-participation screening of college athletes. (2008) (37)
- Life cycles of cardiac α1- and β-adrenergic receptors (1987) (37)
- Central nervous system side effects of beta-adrenergic blocking agents with high and low lipid solubility. (1989) (37)
- Persistent Value of the Stethoscope in the Age of COVID-19 (2020) (36)
- B-type natriuretic peptide: the level and the drug--partners in the diagnosis of congestive heart failure. (2004) (36)
- Combination of B-type natriuretic peptide levels and non-invasive hemodynamic parameters in diagnosing congestive heart failure in the emergency department. (2004) (36)
- Role of guanine nucleotide regulatory proteins in insulin stimulation of glucose transport in rat adipocytes. Influence of bacterial toxins. (1989) (35)
- Quinidine is a competitive antagonist at alpha 1- and alpha 2-adrenergic receptors. (1984) (35)
- Clinical Applications of Biomarkers in Atrial Fibrillation. (2017) (34)
- Continuous electrocardiographic monitoring in patients with sickle‐cell anemia during pain crisis (1983) (34)
- Decreased adrenergic sensitivity in patients with hypothyroidism. (1990) (34)
- Plasma bioactive adrenomedullin as a prognostic biomarker in acute heart failure. (2016) (34)
- Prognosis of stage A or B heart failure patients with elevated B-type natriuretic peptide levels. (2010) (34)
- Volume overload and cardiorenal syndromes. (2010) (34)
- Cardiac Troponin Values in Patients With Acute Coronary Syndrome and Sleep Apnea: A Pilot Study (2017) (34)
- Cardiac biomarkers, mortality, and post-traumatic stress disorder in military veterans. (2012) (34)
- Clinical relevance of biomarkers in heart failure and cardiorenal syndrome: the role of natriuretic peptides and troponin (2014) (34)
- Atrial Natriuretic Peptide and Treatment With Sacubitril/Valsartan in Heart Failure With Reduced Ejection Fraction. (2020) (33)
- Natriuretic peptide testing for predicting adverse events following heart failure hospitalization. (2012) (33)
- Cerebral salt wasting and elevated brain natriuretic peptide levels after traumatic brain injury: 2 case reports. (2008) (33)
- Prevention of cardio-renal syndromes: workgroup statements from the 7th ADQI Consensus Conference. (2010) (33)
- What is in the differential diagnosis of a B-type natriuretic peptide level of 1,000 pg/ml? (2003) (32)
- B-type natriuretic peptide: a strong predictor of early and late mortality in patients with acute chest pain without ST-segment elevation in the emergency department (2009) (32)
- Serial ST2 testing in hospitalized patients with acute heart failure. (2015) (32)
- Do we need another heart failure biomarker: focus on soluble suppression of tumorigenicity 2 (sST2). (2016) (31)
- Lack of inotropic effects of neuropeptide Y in human myocardium. (1989) (31)
- The role of procalcitonin in acute heart failure patients (2017) (31)
- Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study. (2006) (31)
- Effect of nesiritide in combination with standard therapy on serum concentrations of natriuretic peptides in patients admitted for decompensated congestive heart failure. (2005) (31)
- Circulating heart failure biomarkers beyond natriuretic peptides: review from the Biomarker Study Group of the Heart Failure Association (HFA), European Society of Cardiology (ESC) (2021) (30)
- How B-Type Natriuretic Peptide (BNP) and Body Weight Changes Vary in Heart Failure With Preserved Ejection Fraction Compared With Reduced Ejection Fraction: Secondary Results of the HABIT (HF Assessment With BNP in the Home) Trial. (2016) (30)
- B-type natriuretic peptide (BNP) levels: diagnostic and therapeutic potential. (2001) (30)
- Pertussis toxin treatment of whole blood. A novel approach to assess G protein function in congestive heart failure. (1990) (29)
- Complex ventricular arrhythmias in patients with Q wave versus non-Q wave myocardial infarction. (1985) (29)
- Propranolol treatment affects parameters of human immunity. (1991) (29)
- Mid‐region pro‐adrenomedullin adds predictive value to clinical predictors and Framingham risk score for long‐term mortality in stable outpatients with heart failure (2013) (29)
- The Impact of Substance Abuse on Heart Failure Hospitalizations. (2020) (29)
- Use of BNP Levels in Monitoring Hospitalized Heart Failure Patients with Heart Failure (2003) (28)
- Prognostic Significance of Biomarkers in Predicting Outcome in Patients With Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Biomarker Substudy of the Surgical Treatment for Ischemic Heart Failure Trials (2013) (28)
- The effect of diabetes on B-type natriuretic peptide concentrations in patients with acute dyspnea: an analysis from the Breathing Not Properly Multinational Study. (2004) (26)
- Tachyphylaxis with amrinone therapy: association with sequestration and down-regulation of lymphocyte beta-adrenergic receptors. (1989) (26)
- The utility of biomarkers in sorting out the complex patient. (2010) (26)
- Absence of cardioversion-induced ventricular arrhythmias in patients with therapeutic digoxin levels. (1985) (26)
- Prognostic Usefulness of Proenkephalin in Stable Ambulatory Patients With Heart Failure. (2016) (26)
- Proenkephalin (PENK) as a Novel Biomarker for Kidney Function. (2017) (26)
- Updating the Role of Natriuretic Peptide Levels in Cardiovascular Disease (2011) (26)
- Laboratory parameters of cardiac and kidney dysfunction in cardio-renal syndromes (2011) (26)
- Practical approaches to treating patients with acute decompensated heart failure. (2001) (25)
- The Role of Biomarkers in Detection of Cardio-toxicity (2017) (25)
- B-type natriuretic peptide levels (2007) (25)
- Sacubitril‐Valsartan in a routine community population: attention to volume status critical to achieving target dose (2020) (25)
- Beta-adrenergic receptors and the Gs protein in myocardial ischemia and injury. (1990) (24)
- Screening for asymptomatic left ventricular dysfunction using B-type natriuretic Peptide. (2008) (24)
- Current and novel biomarkers in heart failure: bench to bedside (2016) (24)
- Usefulness of B-type natriuretic peptide levels in predicting hemodynamic and clinical decompensation. (2009) (24)
- Cardiac magnetic resonance in heart failure with preserved ejection fraction: myocyte, interstitium, microvascular, and metabolic abnormalities (2020) (24)
- Soluble ST2 in end‐stage heart failure, before and after support with a left ventricular assist device (2018) (24)
- Critical pathway for the management of acute heart failure at the Veterans Affairs San Diego Healthcare System: transforming performance measures into cardiac care. (2008) (24)
- Mitigation of beta 1- and/or beta 2-adrenoceptor function in human heart failure. (1990) (23)
- B‐type natriuretic peptide trend predicts clinical significance of worsening renal function in acute heart failure (2019) (23)
- Biomarkers in heart failure (2010) (23)
- Japanese-Western consensus meeting on biomarkers. (2011) (23)
- Sleep and health-related quality of life in heart failure. (2009) (22)
- Short‐term prognostic implications of serum and urine neutrophil gelatinase‐associated lipocalin in acute heart failure: findings from the AKINESIS study (2019) (22)
- Heart Failure Biomarkers (2013) (22)
- Reverse Cardiac Remodeling and Outcome After Initiation of Sacubitril/Valsartan. (2020) (22)
- Inpatient monitoring and prognostic importance of B-type natriuretic peptide. (2008) (22)
- A Prospective Study of an Algorithm Using Cardiac Troponin I and Myoglobin as Adjuncts in the Diagnosis of Acute Myocardial Infarction and Intermediate Coronary Syndromes in a Veteran's Hospital (2000) (22)
- Diagnosis of heart failure. (2009) (22)
- Reduced readmission rate for alternating diagnoses of heart failure and pulmonary disease after implementation of B‐type natriuretic peptide testing (2004) (22)
- Evolving use of biomarkers for kidney injury in acute care settings (2010) (21)
- Utility of Urine Neutrophil Gelatinase-Associated Lipocalin for Worsening Renal Function during Hospitalization for Acute Heart Failure: Primary Findings of the Urine N-gal Acute Kidney Injury N-gal Evaluation of Symptomatic Heart Failure Study (AKINESIS). (2019) (21)
- The utility of galectin-3 for predicting cause-specific death in hospitalized patients with heart failure. (2015) (21)
- The Confounding Effects of Non-cardiac Pathologies on the Interpretation of Cardiac Biomarkers (2018) (21)
- Reverse Cardiac Remodeling Following Initiation of Sacubitril/Valsartan in Patients With Heart Failure With and Without Diabetes. (2020) (21)
- Comparison between mixed venous oxygen saturation and thermodilution cardiac output in monitoring patients with severe heart failure treated with milrinone and dobutamine. (1998) (21)
- Comparability of Results between Point-of-Care and Automated Instruments to Measure B-type Natriuretic Peptide (2010) (21)
- Novel biomarkers in heart failure with preserved ejection fraction. (2014) (21)
- Natriuretic peptide-guided therapy for heart failure: ready for "battle" or too "scarred" by the challenges of trial design? (2009) (21)
- Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction (2020) (20)
- ST2 and multimarker testing in acute decompensated heart failure. (2015) (20)
- Clinical Characteristics and Outcomes of Patients with Heart Failure and Methamphetamine Abuse. (2020) (20)
- Biomarkers of heart failure. (2010) (20)
- Understanding B-type natriuretic peptide and its role in diagnosing and monitoring congestive heart failure. (2005) (20)
- Opinion paper on utility of point-of-care biomarkers in the emergency department pathways decision making (2014) (20)
- B-type natriuretic peptide and impedance cardiography at the time of routine echocardiography predict subsequent heart failure events. (2009) (20)
- Risk stratification scores for patients with acute heart failure in the Emergency Department: A systematic review (2020) (20)
- In vivo regulation of beta-adrenergic receptors on mononuclear leukocytes and heart. Assessment of receptor compartmentation after agonist infusion and acute aortic constriction in guinea pigs. (1988) (19)
- Cardiorenal biomarkers in acute heart failure (2012) (19)
- Beta-adrenoceptor control of immune function in congestive heart failure. (1990) (19)
- Sex‐based differences in biomarkers, health status, and reverse cardiac remodelling in patients with heart failure with reduced ejection fraction treated with sacubitril/valsartan (2020) (19)
- Beta-adrenergic receptors in congestive heart failure: present knowledge and future directions. (1989) (19)
- Association of BNP and Troponin Levels with Outcome among Cardiac Resynchronization Therapy Recipients (2015) (18)
- Validation of Plasma Proneurotensin as a Novel Biomarker for the Prediction of Incident Breast Cancer (2014) (18)
- N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]). (2020) (18)
- Improve Management of acute heart failure with ProcAlCiTonin in EUrope: results of the randomized clinical trial IMPACT EU Biomarkers in Cardiology (BIC) 18 (2019) (18)
- Multimarker testing with ST2 in chronic heart failure. (2015) (18)
- Association Between Angiotensin Receptor–Neprilysin Inhibition, Cardiovascular Biomarkers, and Cardiac Remodeling in Heart Failure With Reduced Ejection Fraction (2021) (17)
- Natriuretic peptides in acute coronary syndromes: prognostic value and clinical implications. (2008) (17)
- Serum alarmin S100A8/S100A9 levels and its potential role as biomarker in myocarditis (2020) (17)
- B-type natriuretic peptide in heart failure: diagnostic, prognostic, and therapeutic use. (2005) (17)
- Troponin in Heart Failure. (2018) (17)
- Torsades de pointes precipitated by a Chinese herbal remedy. (1987) (17)
- Cardiovascular and Renal Surrogate Markers in the Clinical Management of Hypertension (2009) (17)
- Observation of stethoscope sanitation practices in an emergency department setting (2019) (17)
- Improvement of Health Status Following Initiation of Sacubitril/Valsartan in Heart Failure and Reduced Ejection Fraction. (2020) (16)
- Myopericarditis and pericarditis in the deployed military member: a retrospective series. (2013) (16)
- Pro-substance p for evaluation of risk in acute myocardial infarction. (2014) (16)
- Updated algorithms for using B-type natriuretic peptide (BNP) levels in the diagnosis and management of congestive heart failure. (2002) (16)
- Implantable Cardioverter-Defibrillator Eligibility After Initiation of Sacubitril/Valsartan in Chronic Heart Failure: Insights From PROVE-HF (2021) (16)
- Usefulness of serial assessment of natriuretic peptides in the emergency department for patients with acute decompensated heart failure. (2008) (15)
- Utility of natriuretic peptides to assess and manage patients with heart failure receiving angiotensin receptor blocker/neprilysin inhibitor therapy (2018) (15)
- Heart failure with preserved ejection fraction: a nephrologist-directed primer (2017) (15)
- Biomarkers in heart failure. Does prognostic utility translate to clinical futility? (2007) (15)
- The potential role of natriuretic peptide-guided management for patients hospitalized for heart failure. (2015) (15)
- Increasing aminoterminal-pro-B-type natriuretic peptide precedes the development of arterial hypertension: the multiethnic study of atherosclerosis (2015) (15)
- Emergency department perspectives on B-type natriuretic peptide utility. (2008) (15)
- Heart Failure With Recovered Ejection Fraction in African Americans: Results From the African-American Heart Failure Trial. (2017) (14)
- Using biomarkers to guide heart failure management (2017) (14)
- Procalcitonin predicts mortality in HIV‐infected Ugandan adults with lower respiratory tract infections (2014) (14)
- B-type natriuretic peptide levels predict extent and severity of coronary disease in non-ST elevation coronary syndromes and normal left ventricular systolic function (2011) (14)
- Fluid overload : diagnosis and management (2010) (14)
- Brain natriuretic peptide-guided therapy in the inpatient management of decompensated heart failure (2012) (14)
- Challenges in Acute Heart Failure Clinical Management: Optimizing Care Despite Incomplete Evidence and Imperfect Drugs (2015) (14)
- Novel biomarkers for heart failure (2013) (14)
- Beside B-type natriuretic peptide in the emergency diagnosis of systolic and nonsystolic heart failure: Results from the breathing not properly (BNP) multinational study (2003) (13)
- Delayed air embolism simulating pulmonary thromboembolism in the intensive care unit: Role of echocardiography (1994) (13)
- Characteristics and Outcomes of Methamphetamine Abuse Among Veterans With Heart Failure. (2019) (13)
- Acoustic cardiography S3 detection use in problematic subgroups and B-type natriuretic peptide "gray zone": secondary results from the Heart failure and Audicor technology for Rapid Diagnosis and Initial Treatment Multinational Investigation. (2011) (13)
- Mid-regional pro-adrenomedullin improves disposition strategies for patients with acute dyspnoea: results from the BACH trial (2012) (13)
- Testing for B-type natriuretic peptide in the diagnosis and assessment of heart failure: what are the nuances? (2004) (12)
- ST2 elevation in heart failure, predictive of a high early mortality (2018) (12)
- Cardiovascular disease in patients with chronic renal impairment: role of natriuretic peptides. (2008) (12)
- Biomarkers of cardiac and kidney dysfunction in cardiorenal syndromes. (2010) (12)
- Bioimpedance Vector Analysis (BIVA) for Diagnosis and Management of Acute Heart Failure (2014) (12)
- Effect on Survival of Concurrent Hemoconcentration and Increase in Creatinine During Treatment of Acute Decompensated Heart Failure. (2019) (12)
- Predictive value for death and rehospitalization of 30-day postdischarge B-type natriuretic peptide (BNP) in elderly patients with heart failure. Sub-analysis of Italian RED Study (2015) (12)
- Neutrophil gelatinase-associated lipocalin as diagnostic and prognostic tool for cardiovascular disease and heart failure. (2013) (12)
- Serial sampling of copeptin levels improves diagnosis and risk stratification in patients presenting with chest pain: results from the CHOPIN trial (2015) (12)
- Atherosclerotic coronary artery aneurysm progressing to coronary artery fistula: presentation as myocardial infarction with continuous murmur. (1987) (11)
- Soluble ST2 – a new biomarker in heart failure (2019) (11)
- Aseptic Barriers Allow a Clean Contact for Contaminated Stethoscope Diaphragms (2020) (11)
- Racial and Ethnic Differences in Biomarkers, Health Status, and Cardiac Remodeling in Patients With Heart Failure With Reduced Ejection Fraction Treated With Sacubitril/Valsartan (2020) (11)
- Mitigation of β1- and/or β2-adrenoceptor function in human heart failure (1990) (11)
- B-type natriuretic peptide as an independent predictor of coronary disease extension in non-ST elevation coronary syndromes with preserved systolic function (2012) (10)
- Decongestion discriminates risk for one‐year mortality in patients with improving renal function in acute heart failure (2021) (10)
- Soluble ST 2 Testing : A Promising Biomarker in the Management of Heart Failure (2016) (10)
- Evaluation of B-type natriuretic peptide (BNP) levels in normal and preeclamptic women (2004) (10)
- Changes in N-terminal pro-B-type natriuretic peptide and incidence of diabetes: The Multi-Ethnic Study of Atherosclerosis (MESA). (2015) (10)
- Recent advances in point-of-care testing for natriuretic peptides: potential impact on heart failure diagnosis and management (2016) (10)
- Biomarker-guided treatment of congestive heart failure. (2010) (10)
- Midregional proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain: results from the CHOPIN trial. (2015) (9)
- Soluble ST2 Is a Sensitive and Specific Biomarker for Fulminant Myocarditis (2022) (9)
- Algorithms for using B-type natriuretic peptide levels in the diagnosis and management of congestive heart failure. (2002) (9)
- What causes elevated B-type natriuretic peptide in patients without heart failure? (2003) (9)
- Growth differentiation factor-15, a novel systemic biomarker of oxidative stress, inflammation, and cellular aging: Potential role in cardiovascular diseases (2021) (9)
- Cardiovascular health of nonagenarians in southern Italy: a cross-sectional, home-based pilot study of longevity. (2019) (9)
- Utilization of galectin-3 in case management across the spectrum of heart failure. (2014) (9)
- The role of natriuretic peptides: from the emergency department throughout hospitalization. (2012) (8)
- The utility of heart sounds and systolic intervals across the care continuum. (2006) (8)
- Sacubitril/Valsartan, Cardiac Fibrosis, and Remodeling in Heart Failure. (2019) (8)
- Usefulness of Proneurotensin to Predict Cardiovascular and All-Cause Mortality in a United States Population (from the Reasons for Geographic and Racial Differences in Stroke Study). (2018) (8)
- North American B-Type Natriuretic Peptide (BNP) Consensus Working Group. (2008) (8)
- Prevalence of Sleep Disordered Breathing in Congestive Heart Failure (2006) (8)
- Algorithms for assessing cardiovascular risk in women. (2007) (8)
- Impact of systemic hypertension on the diagnostic performance of B-type natriuretic peptide in patients with acute dyspnea. (2009) (8)
- Adiponectin is independently associated with NT-proBNP: The Multi-Ethnic Study of Atherosclerosis. (2015) (8)
- Rupture of the ventricular septum and right ventricle complicating acute myocardial infarction. (1988) (7)
- B-type natriuretic peptide: time to incorporate natriuretic peptides in our practice (2006) (7)
- B-type natriuretic peptide. A biomarker for all the right reasons. (2004) (7)
- Evolving use of B-type natriuretic peptide in clinical practice. (2004) (7)
- Computerized tomography measured liver fat is associated with low levels of N-terminal pro-brain natriuretic protein (NT-proBNP). Multi-Ethnic Study of Atherosclerosis. (2016) (7)
- Rationale and design of the IMPACT EU-trial: improve management of heart failure with procalcitonin biomarkers in cardiology (BIC)-18 (2018) (7)
- Impact of the history of congestive heart failure on accuracy of BNP in the emergency diagnosis of heart failure: results from the breathing not properly (BNP) multinational study (2004) (6)
- Early identification of acute heart failure at the time of presentation: do natriuretic peptides make the difference? (2018) (6)
- Potential Utility of Cardio-Renal Biomarkers For Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure: Cardio-Renal Biomarkers and WRF in AHF. (2020) (6)
- Relation of Decongestion and Time to Diuretics to Biomarker Changes and Outcomes in Acute Heart Failure. (2021) (6)
- INCREASED 90-DAY MORTALITY IN PATIENTS WITH ELEVATED COPEPTIN: SECONDARY RESULTS FROM THE BIOMARKERS IN ACUTE HEART FAILURE (BACH) STUDY (2010) (6)
- Soluble ST2: A biomarker to monitor heart failure progression and treatment (2018) (6)
- Stethoscope as a Vector for Infectious Disease (2018) (6)
- The current and future landscape of urinary thromboxane testing to evaluate atherothrombotic risk. (2014) (6)
- Evolution of B-type natriuretic peptide in evaluation of intensive care unit shock. (2004) (6)
- Natriuretic peptides as diagnostic test: lessons from the first 5 years of clinical application. (2006) (6)
- B-type natriuretic peptide levels are inversely related to body mass index in patients with heart failure (2003) (6)
- Coronary thrombosis precipitated by hyperventilation-induced vasospasm. (1988) (6)
- Heart Failure and Audicor Technology for Rapid Diagnosis and Initial Treatment of ED Patients with Suspected Heart Failure (HEARD-IT) (2007) (6)
- The association between N-terminal pro B-type natriuretic peptide and lipoprotein particle concentration plateaus at higher N-terminal pro B-type natriuretic peptide values: Multi-Ethnic Study on Atherosclerosis. (2015) (6)
- An update on the use and discovery of prognostic biomarkers in acute decompensated heart failure (2019) (6)
- Copeptin to rule out myocardial infarction in Blacks versus Caucasians (2019) (6)
- Multiple marker approach to risk stratification in patients with stable coronary artery disease: to have or have not. (2010) (5)
- Routine measurement of natriuretic peptide to guide the diagnosis and management of chronic heart failure. (2004) (5)
- Highlights of the Year in JACC 2008. (2009) (5)
- Biomarkers in Hypertension and Their Relationship with Myocardial Target-Organ Damage (2014) (5)
- The stethoscope: a potential vector for COVID-19? (2020) (5)
- B-type natriuretic peptide levels in patients in the emergency department with possible heart failure and previous stable angina pectoris and/or healed myocardial infarction. (2005) (5)
- Natriuretic Peptides in Clinical Practice (2008) (5)
- sST2 for Outcome Prediction in Acute Heart Failure: Which Is the Best Cutoff? (2019) (5)
- Soluble ST 2 Monitoring Provides Additional Risk Stratification for Outpatients With Decompensated Heart Failure (2017) (5)
- Post-acute care: the role of natriuretic peptides. (2012) (5)
- Necessity of hospitalization and stress testing in low risk chest pain patients (2017) (5)
- The use of B-type natriuretic peptides in the intensive care unit. (2008) (5)
- Quinidine is a Competitive Antagonist at α1‐ and α2Adrenergic Receptors (1984) (5)
- Using galectin-3 to reduce heart failure rehospitalization. (2014) (5)
- Development, validation and implementation of biomarker testing in cardiovascular medicine state-of-the-art: Proceedings of the European Society of Cardiology - Cardiovascular Round Table. (2020) (4)
- Faculty Opinions recommendation of Bio-adrenomedullin as a marker of congestion in patients with new-onset and worsening heart failure. (4)
- Genetic Variants Are Not Associated with Outcome in Patients with Coronary Artery Disease and Left Ventricular Dysfunction: Results of the Genetic Substudy of the Surgical Treatment for Ischemic Heart Failure (STICH) Trials (2015) (4)
- Potential Utility of Cardiorenal Biomarkers for Prediction and Prognostication of Worsening Renal Function in Acute Heart Failure (2021) (4)
- The relationship of circulating relaxin‐2 concentrations with short‐term prognosis in patients with acute heart failure: the RELAHF study (2017) (4)
- 238: Does Time to IV Diuretic Matter in the Emergency Treatment of Acute Decompensated Heart Failure? (2007) (4)
- Review on natriuretic peptides: where we are, where we are going. (2008) (4)
- Defective signal transduction in T lymphocytes. (1989) (4)
- Cardiac Biomarkers. Expert Advice For Clinicians (2012) (4)
- The appropriate use of biomarkers in heart failure. (2012) (4)
- Alpha1- and Beta-Adrenergic Receptors in Myocardial Ischemia and Injury (1989) (4)
- The effect of diabetes on the diagnostic and prognostic performance of mid-region pro-atrial natriuretic peptide and mid-region pro-adrenomedullin in patients with acute dyspnea (2012) (4)
- New Targets in the Drug Treatment of Heart Failure (2016) (4)
- IMPROVED SURVIVAL IN PATIENTS WITH DIASTOLIC HEART FAILURE DISCHARGED ON BETA-BLOCKER AND ACE INHIBITORS (2013) (4)
- B-type natriuretic Peptide: application in the community. (2008) (4)
- Utility of B-natriuretic peptide (BNP) in the diagnosis of congestive heart in an urgent care setting (2000) (4)
- Toward Precision Medicine in the Cardiorenal Syndrome. (2018) (4)
- Comprar Fluid overload. Diagnosis and management (contributions to nephrology, vol. 164) | Ronco, C. | 9783805594165 | Karger AG (2010) (4)
- Biomarker developments in heart failure: 2016 and beyond (2019) (4)
- Artificial intelligence MacHIne learning for the detection and treatment of atrial fibrillation guidelines in the emergency department setting (AIM HIGHER): Assessing a machine learning clinical decision support tool to detect and treat non‐valvular atrial fibrillation in the emergency department (2021) (3)
- 1001-25 Primary results of the rapid emergency department heart failure outpatient trial (REDHOT): A multicenter trial examining B-type natriuretic peptide levels, emergency physician decision making and outcomes in patients presenting with shortness of breath (2004) (3)
- Finding acute coronary syndrome with serial troponin testing for rapid assessment of cardiac ischemic symptoms (FAST-TRAC): a study protocol (2022) (3)
- Highlights of the Year in JACC 2011. (2012) (3)
- Highlights of the year in JACC 2013. (2014) (3)
- Special Japanese-Western Consensus Meeting on Biomarkers Executive Summary (2011) (3)
- Disparity of care in the acute care of patients with heart failure. (2011) (3)
- The Indian Consensus Document on cardiac biomarker (2014) (3)
- Associations of cardiac injury biomarkers with risk of peripheral artery disease: The Multi-Ethnic Study of Atherosclerosis. (2021) (3)
- The independent contribution to elevations in B-type natriuretic peptide from atrial fibrillation (2002) (3)
- Decongestion, kidney injury and prognosis in patients with acute heart failure. (2022) (3)
- Elevated Mid-Region Pro-Adrenomedullin is Associated with Increased Mortality in Stable Outpatients with Diastolic Dysfunction (2011) (3)
- Highlights of the year in JACC 2012. (2013) (3)
- The prognostic value of copeptin in patients with acute chest pain (2014) (3)
- Cardiac Biomarkers for Better Management of Acute Coronary Syndromes. (2015) (3)
- Uncovering heart failure in patients with bronchospasm: Rationale for the early use of B-type natriuretic peptide in the emergency department (2003) (3)
- Does verapamil act as an immunomodulatory drug in vivo? (1991) (3)
- Life cycles of cardiac alpha 1- and beta-adrenergic receptors. (1987) (3)
- Comparison of the effects of d-amphetamine and lysergic acid diethylamide in two strains of rats having different behavioral baselines. (1976) (3)
- B-type natriuretic peptide adds to clinical judgement in the diagnosis of heart failure: a bayesian analysis from the BNP multinational study (2002) (3)
- Circulating natriuretic peptide levels in acute heart failure. (2007) (3)
- Advancements in biomarkers for cardiovascular disease: diagnosis, prognosis, and therapy (2021) (2)
- Elevated NT-proBNP Levels are Associated with Poor Cognitive Function in Community-Dwelling Older Adults: Results from the Rancho Bernardo Study (2011) (2)
- B-type natriuretic peptide blood levels identify patients with non-ST elevation acute coronary syndromes at high risk for complications during intravenous beta-blocker infusion (2011) (2)
- Biomarkers for Diagnosis and Prognosis of Acute Heart Failure (2013) (2)
- Acute coronary syndrome: the Time is Life Campaign at the Veterans Administration Medical Center San Diego. (2006) (2)
- Natriuretic Peptides and Biomarkers in the Diagnosis of Heart Failure (2015) (2)
- B-type natriuretic peptide in the neurohormonal hierarchy in heart failure (2004) (2)
- A rapid, bedside test for brain natriuretic peptide accurately delineates both systolic and diastolic dysfunction in patients referred for echocardiography (2000) (2)
- Primary results of the BNP multinational study: B-type natriuretic peptide in the emergency diagnosis of heart failure (2002) (2)
- Integration of B-type natriuretic Peptide in heart failure outpatient programs. (2008) (2)
- Clinical Use of Natriuretic Peptides for the Diagnosis and Management of Heart Failure (2006) (2)
- The GUIDE-HF trial of pulmonary artery pressure monitoring in heart failure: impact of the COVID-19 pandemic (2022) (2)
- B-type natriuretic peptide-guided therapy and prognosis in acutely ill patients with pulmonary disease. (2007) (2)
- Natriuretic peptides, novel biomarkers, and the prediction of future events. (2013) (2)
- The effect of diabetes on B-type natriuretic peptide levels in patients with acute dyspnea (2002) (2)
- Cardiovascular Disease in Patients With Chronic Renal Impairment: Role of Natriuretic Peptides (2008) (2)
- Development of Therapeutics for Heart Failure A Global Rank End Point for Clinical Trials in Acute Heart Failure (2010) (2)
- Emergency department perspectives on B-type natriuretic peptide utility. (2008) (2)
- Algorithms in Heart Failure (2018) (2)
- Abstract 1680: Elevated NT-proBNP Levels Are Associated With Poor Cognitive Function in Apparently Healthy Older Adults: Results From the Rancho Bernardo Study (2009) (2)
- Galectin 3: Newest Marker of HF Outcomes (2014) (2)
- Use of biomarkers in evaluation of patients with heart failure. (2010) (2)
- ELEVATED COPEPTIN IS ASSOCIATED WITH INCREASED 90 DAY MORTALITY IN PATIENTS WITH ACUTE DYSPNEA FROM NON-CARDIAC CAUSES: SECONDARY RESULTS FROM THE BIOMARKERS IN ACUTE HEART FAILURE (BACH) STUDY (2012) (2)
- Biomarkers: a window into the pathophysiology of atrial fibrillation in heart failure with reduced vs. preserved ejection fraction (2018) (2)
- Bioimpedance Vector Analysis in the Diagnosis of Acute Decompensated Heart Failure in the Emergency Department (2012) (2)
- Highlights of the Year in JACC 2006. (2007) (2)
- Galectin-3 After Heart Transplantation: Does it Get Better? (2016) (2)
- ProBNP Represents “Altered Forms” of BNP in Acute Decompensated Congestive Heart Failure (2007) (2)
- Highlights of the Year in JACC 2009. (2010) (2)
- Age Differences in Effects of Sacubitril/Valsartan on Cardiac Remodeling, Biomarkers, and Health Status. (2022) (2)
- Effects of Angiotensin Receptor/Neprilysin Inhibitor Therapy on Amino-terminal Pro-B-Type Natriuretic Peptide and Cardiac Remodeling in Heart Failure with Reduced Ejection Fraction: The PROVE-HF Study (2019) (2)
- Diagnostic laparotomy. (1977) (2)
- 152: Audicor S3 Outperforms Emergency Physicians’ Ability to Diagnose Acute Heart Failure at the Bedside (2007) (2)
- Serial High Sensitive Troponin I Predicts Outcome in Patients With Acute Heart Failure (2010) (1)
- Comparative Effect of Angiotensin Receptor Neprilysin Inhibition on B-type Natriuretic Peptide Levels Measured by Three Different Assays: The PROVE-HF Study. (2022) (1)
- Sex-based Differences in Biomarkers, Quality of Life, and Reverse Cardiac Remodeling in Patients with Heart Failure with Reduced Ejection Fraction Treated with Sacubitril/valsartan (2020) (1)
- Comparison of a Point-of-Care Method To Measure BNP Levels with a Standard Lab-Based Instrument in Patients with Congestive Heart Failure (2008) (1)
- NGAL Is Independently Associated with Cardiovascular Death and All-Cause Mortality in Community-Dwelling Older Adults with Stage A Heart Failure (2011) (1)
- Highlights of the year in JACC 2010. (2011) (1)
- Cardiac biomarkers: Case studies and clinical correlations (2016) (1)
- Comparability of Results Between a Point-of-Care and an Automated Instrument for Measurement of B-Type Natriuretic Peptide (2010) (1)
- Abstract 14066: Methamphetamine Associated Heart Failure, a New Epidemic (2017) (1)
- Variability in Measurement of BNP in Routine Evaluation of Heart Failure(VAMPIRE) (2012) (1)
- B-type natriuretic peptide in the emergency department: a valuable diagnostic aid. (2005) (1)
- Pertussis Toxin Treatment of Whole Blood (2005) (1)
- Prognosis is worse with elevated cardiac troponin in nonacute coronary syndrome compared with acute coronary syndrome (2022) (1)
- 859-2 Utility of B-natriuretic peptide levels in predicting outcome of hospitalized patients with congestive heart failure: Results of the breathing not properly (BNP) multinational study (2004) (1)
- Procalcitonin Use to Identify the Infected Heart Failure Patient (2013) (1)
- Natriuretic peptide levels: what's on the horizon? (2008) (1)
- Highlights of the year in JACC 2007. (2008) (1)
- f-Adrenergic Receptors in Lymphocyte Subsets After Exercise Alterations in Normal Individuals and Patients With Congestive Heart Failure* (2005) (1)
- B-type natriuretic peptide and renal function in the diagnosis of heart failure: An analysis from the BNP multinational study (2003) (1)
- ELEVATED MID-REGIONAL PRO-ADRENOMEDULLIN IS ASSOCIATED WITH INCREASED MORTALITY IN STABLE OUTPATIENTS WITH DIASTOLIC DYSFUNCTION (2011) (1)
- Update on Natriuretic Peptides: Present Practices and Future Opportunities (2006) (1)
- The Presence of an S3 Is Associated with an Increased Rate of Adverse Cardiac Events (2007) (1)
- Machine learning with D-dimer in the risk stratification for pulmonary embolism: a derivation and internal validation study. (2021) (1)
- Prognostic value of brain natriuretic peptide vs history of heart failure hospitalization in a large real‐world population (2020) (1)
- Hypervolemic and optivolemic natriuretic peptides in acute heart failure. (2011) (1)
- RATIONALE AND METHODS OF THE PROSPECTIVE STUDY OF BIOMARKERS, SYMPTOM IMPROVEMENT AND VENTRICULAR REMODELING DURING ENTRESTO THERAPY FOR HEART FAILURE (PROVE-HF) STUDY (2017) (1)
- Cardiac biomarkers: a contemporary status report (2006) (1)
- Evaluation of B-Type natriuretic peptide (BNP) levels in patients at elevated risk for preeclampsia (2005) (1)
- Presentation of AMI—Symptoms, Examination, Biomarkers and Atypical Presentations (2010) (1)
- Title Page / List of Contents / Preface (2010) (1)
- Natriuretic Peptides in Heart Failure Moderators : (2014) (1)
- Early Improvement Of Dyspnea And Neurohormonal Status Using Minute Ventilation-Targeted Adaptive Servo Ventilation in Acute Heart Failure (2015) (1)
- Natriuretic peptides: diagnostic tools and predictors of heart failure outcome. (2006) (1)
- Troponin-Guided Heart Failure Therapy: Are We There Yet? (2016) (1)
- Response to letter to the editor by Cheng (2006) (1)
- A rapid BNP assay accurately diagnoses left ventricular dysfunction and heart failure: a multicenter study (2002) (1)
- Chapter 37 – The Use of Biomarkers in the Evaluation of Heart Failure (2011) (1)
- Prospective search for an optimal BNP level to screen patients with suspected left ventricular dysfunction (2003) (1)
- 88: Acute Heart Failure Mortality Prediction Using Copeptin: Results of the Biomarkers in ACute Heart Failure Trial (2009) (1)
- Minute Ventilation-Targeted Adaptive Servo Ventilation Protects Renal Function In Acute Decompensated Heart Failure Patients (2015) (1)
- Faculty Opinions recommendation of sST2 Predicts Outcome in Chronic Heart Failure Beyond NT-proBNP and High-Sensitivity Troponin T. (1)
- Biomarkers in acute heart failure (2018) (1)
- Working Group on Emergency Department Management of Acute Heart Failure Research Challenges and Opportunities (1)
- The effect of nesiritide on serum levels of B-natriuretic peptide (BNP) and N-terminal proBNP (NT-proBNP) in patients admitted for decompensated congestive heart failure (2004) (1)
- COPEPTIN PROVIDES PROGNOSTIC VALUE IN PATIENTS WITH ACUTE CHEST PAIN (2014) (1)
- SERIAL SAMPLING OF MIDREGION PROADRENOMEDULLIN IS PREDICTIVE OF SHORT TERM MORTALITY IN PATIENTS ADMITTED FOR SHORTNESS OF BREATH (2015) (0)
- proadrenomedullin predicts mortality and major adverse cardiac events in patients presenting with chest pain : Results from the CHOPIN trial Permalink (2015) (0)
- Prognostic role of brain natriuretic peptide (BNP) levels in patients with type 2 diabetes mellitus (2004) (0)
- Front & Back Matter (2013) (0)
- Initiation of Angiotensin Converting Enzyme Inhibitors and Beta-blockers in Heart Failure: Putting Evidence into Practice (2018) (0)
- Comprar Algorithms In Heart Failure | Alan S. Maisel | 9789385999642 | Jaypee (2016) (0)
- Chapter-28 Hypertrophic Cardiomyopathy (2018) (0)
- B-natriuretic peptide concentrations had high sensitivity and specificity for detecting abnormal ventricular function (2002) (0)
- Procalcitonin Is Associated With Increased In-Hospital Mortality In A Ugandan Cohort With Pneumonia And High Prevalence Of HIV (2012) (0)
- ST2 Predicts Mortality in Outpatients Referred for Echocardiograms (2009) (0)
- CHANGES IN URINE NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN WAS NOT ASSOCIATED WITH WORSENING RENAL FUNCTION BUT WITH PROGNOSIS IN PATIENTS WITH ACUTE HEART FAILURE (2019) (0)
- Immune function and myocardial infarction (1991) (0)
- Faculty Opinions recommendation of 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. (0)
- CLINICAL ACUTE KIDNEY INJURY 1 (2014) (0)
- SMALL TROPONIN ELEVATIONS IN HEART FAILURE EXACERBATION PATIENTS ARE ASSOCIATED WITH INCREASED 90-DAY MORTALITY (2010) (0)
- Time to Brain Natriuretic Peptide Decrease and Outcomes in Acute Heart Failure (2018) (0)
- Nesiritide (2018) (0)
- ALTERED FORMS OF BRAIN NATRIURETIC PEPTIDE IN PATIENTS WITH DYSPNEA: DIAGNOSTIC SENSITIVITY AND SPECIFICITY FOR HEART FAILURE (2014) (0)
- Abstract 2856: Effects of Various Treatments on Aspirin Resistance in Patients Presenting to the Emergency Department with Chest Pain: Preliminary Results of the Aspirin Resistance Testing and Initial Strategy for Treatment (ARTIST) Multicenter Trial (2006) (0)
- Response to LTE. #2005-624 - Schwam (2006) (0)
- Atrial Natriuretic Peptide Mediates Reverse Cardiac Remodeling During Treatment with Sacubitril/Valsartan in Patients with Heart Failure with Reduced Ejection Fraction (2020) (0)
- Hospitalization of Low Risk Chest Pain Patients With Normal Troponin and Copeptin (2016) (0)
- Abstract 11415: NGAL is Independently Associated with Cardiovascular Disease and All-Cause Mortality in Community-Dwelling Older Adults: The Rancho Bernardo Study (2011) (0)
- Regulation of Cardiac j 3-Adrenergic Receptors by Captopril Implications for Congestive Heart Failure (2005) (0)
- B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure Analysis From Breathing Not Properly (BNP) Multinational Study Clinical Investigation and Reports (2002) (0)
- Comprar Cardiac Biomarkers. Expert Advice For Clinicians | Alan S. Maisel | 9789350255643 | Jaypee (2012) (0)
- ASSOCIATION OF GALECTIN-3 WITH ECHOCARDIOGRAPHIC MEASUREMENTS AND CARDIOVASCULAR OUTCOMES. (2023) (0)
- 146. Depressive symptoms and cardiovascular risk (2012) (0)
- Abstract 13220: Serial Measurement of NT-proBNP but not Cardiac Troponin T Improves Risk Stratification in the Community: Results from the Rancho Bernardo Study (2010) (0)
- B-Type Natriuretic Peptide Levels and Prediction of Subsequent Heart Failure Events in Class A and B Heart Failure Patients (2007) (0)
- Rapid Bedside S3 Detection in Emergency Department Patients with Acute Dyspnea: Secondary Results from the HEARD-IT Multinational Investigation (2008) (0)
- NO resistance in angiotensin II–induced hypertension is associated with S-nitrosation of soluble guanylyl cyclase (2011) (0)
- B-type natriuretic peptide in the emergency diagnosis of diastolic dysfunction heart failure (2002) (0)
- Use of B-type natriuretic peptide (BNP) as a rapid, point-of-care test for screening patients undergoing echocardiography for ventricular dysfunction (2000) (0)
- NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN PROVIDES ADDITIONAL PROGNOSTIC UTILITY TO HIGH-SENSITIVITY CARDIAC TROPONIN I IN ACUTE HEART FAILURE (2019) (0)
- Stage 0, A, or B Heart Failure with Elevated BNP Carries as Poor a Prognosis as Stage C or D with Low BNP (2008) (0)
- Brain natriuretic peptide and breathing not properly: the merger of 2 BNPs. (2012) (0)
- Correlation Between Troponin Values and Echocardiographic Findings in Children Following Global lschemic Cardiac Arrest (2003) (0)
- Minute Ventilation-Targeted Adaptive Servo Ventilation Improves Subendocardial Injury in Acute Decompensated Heart Failure Patients as Assessed Through Decreases in High-Sensitivity Cardiac Troponin I (2015) (0)
- Increased 90 Day Mortality in Patients With Elevated Copeptin and Low Sodium: Secondary Results from the Biomarkers in the Acute Heart Failure (BACH) Study (2010) (0)
- Abstract 19680: Prognostic Utility of Growth Hormone for All-Cause and Cardiovascular Mortality in a United States National Cohort of Black and White Adults (2016) (0)
- Abstract 3678: Prognostic Value of N-terminal pro-BNP in Apparently Healthy Older Adults: Results from the Rancho Bernardo Study (2007) (0)
- Adrenomedullin Helps Risk Stratify Patients With Pre-Clinical Diastolic Dysfunction (2015) (0)
- The influence of body mass index on clinical interpretation of established and novel biomarkers in acute heart failure. (2023) (0)
- Altered Forms of Brain Natriuretic Peptide in Cardiac Disease (2012) (0)
- N-terminal pro B-Type Natriuretic Peptide (Nt proBNP) and Prediction of Subsequent Heart Failure Events in Class A and B Heart Failure Patients (2007) (0)
- Prognostic Utility of Procalcitonin in Guiding Antibiotic Use in Acute Heart Failure Patients Presenting to the Emergency Department with Dyspnea (2012) (0)
- Use of B-Type Natriuretic Peptide in the Evaluation of Patients with Liver Disease (2006) (0)
- Improved Mortality Associated with ACE-I and Beta Blocker Therapy in Heart Failure with Preserved Ejection Fraction: An Analysis of the Biomarkers in Acute Heart Failure (BACH) Trial (2009) (0)
- NT-PROBNP IS INVERSELY ASSOCIATED WITH LDL-C AND TRIGLYCERIDES BUT FOLLOWING A BIPHASIC PATTERN: THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2013) (0)
- Cardiac biomarkers aid in diagnosing ischemia and heart failure (2001) (0)
- 1049-113 Prospective study in search of an optimal B-type natriuretic peptide level to screen patients for cardiac dysfunction (2004) (0)
- Increased 90 Day Mortality in Patients With Elevated Neopterin: Secondary Results from the Biomarkers in the Acute Heart Failure (BACH) Study (2010) (0)
- Growth-Differentiation Factor-15 Is a Robust, Independent Predictor of 11-Year Mortality Risk in Community-Dwelling Older Adults The left left (2011) (0)
- Does Copeptin Provide Additional Risk Stratification in Chest Pain Patients With a Mild Troponin Elevation (2014) (0)
- Preoperative plasma BNP Level as a predictor of postoperative complications and outcomes in patients undergoing heart surgery (2003) (0)
- TREATMENT WITH SPIRONOLACTONE SIGNIFICANTLY REDUCES 30-DAY HEART FAILURE MORTALITY AND REHOSPITALIZATION (2013) (0)
- Stethoscope hygiene: A legal consideration for cardiologists practicing in a new era of infection control (COVID-19) (2021) (0)
- ASSOCIATION BETWEEN ANGIOTENSIN RECEPTOR-NEPRILYSIN INHIBITION, CARDIOVASCULAR BIOMARKERS AND CARDIAC REMODELING IN HEART FAILURE WITH REDUCED EJECTION FRACTION (2021) (0)
- SUBSTANCE ABUSE AND RISK OF HOSPITALIZATION FOR HEART FAILURE (2019) (0)
- 5: Prevalence of Aspirin Resistance in Patients Presenting to the Emergency Department with Chest Pain (2006) (0)
- CAN A SECOND MEASUREMENT OF COPEPTIN IMPROVE ACUTE MYOCARDIAL INFARCTION RULE OUT (2014) (0)
- Patients Admitted for Acute Heart Failure Have Pronounced Drop in BNP Levels When on Beta Blockers throughout Hospitalization – Italian RED Study (2008) (0)
- PRO-ENDOTHELIN LEVELS PREDICT EMERGENCY DEPARTMENT RE-VISITS IN PATIENTS WITH CHEST PAIN AND CORONARY DISEASE (2016) (0)
- MID-REGIONAL PROADRENOMEDULLIN PREDICTS LONG-TERM MORTALITY IN PATIENTS WITH CHEST PAIN (2014) (0)
- Implications of worsening renal function before hospitalization for acute heart failure (2022) (0)
- Abstract 18557: Low Galectin-3 Identifies Heart Failure Patients at Minimal Risk for Death or Rehospitalization (2014) (0)
- PROGNOSTIC IMPACT OF NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN IN PATIENTS WITH ACUTE HEART FAILURE (AN ANALYSIS OF THE AKINESIS STUDY) (2018) (0)
- RELATIONSHIP BETWEEN CHANGES IN BRAIN NATRIURETIC PEPTIDE AND WORSENING RENAL FUNCTIONS IN ACUTE HEART FAILURE (AN ANALYSIS OF THE AKINESIS STUDY) (2018) (0)
- The Reply. (2021) (0)
- Contents Vol. 40, No. 4, 2015 (2015) (0)
- Abstract 11368: Pre-operative Endothelin Levels Predict Post-operative Acute Kidney Injury in Cardiac Surgery (2016) (0)
- 1 Biomarker Prediction of 14-Day Mortality in Emergency Department Patients Presenting With the Symptom of Acute Shortness of Breath (2011) (0)
- Thirty day post discharge BNP levels predict outcomes better than discharge levels - Italian RED study (2008) (0)
- Management of the Patient with Heart Failure with Preserved Ejection Fraction (2018) (0)
- Biologic markers in acute heart failure (2005) (0)
- 232: The Audicor S3: Use in the BNP Indeterminate Zone and Impact on Physician Clinical Confidence in Acute Heart Failure (2007) (0)
- The Sensitivity and Specificity of the Cardiac S3 in the Emergency Diagnosis of Heart Failure (2007) (0)
- Cardíaca Congestiva Natriuretic Peptides as Prognosticators in Congestive Heart Failure (2006) (0)
- Early Elevations in BNP up to Two Months before Actual Decompensation Predict Heart Failure Hospitalizations (2009) (0)
- B-Type Natriuretic Peptide in the Diagnoses and Management of Congestive Heart Failure (2003) (0)
- Faculty Opinions recommendation of Biomarker-Guided Versus Guideline-Based Treatment of Patients With Heart Failure: Results From BIOSTAT-CHF. (0)
- University of Groningen Improve Management of acute heart failure with ProcAlCiTonin in EUrope (2019) (0)
- Noninvasive Impedance Cardiography Measurements Increase the Diagnostic Ability of B-Type Natriuretic Peptide for Diastolic Heart Failure (2006) (0)
- A comparison of bedside B-type natriuretic peptide versus echocardiographic determination of ejection fraction in the diagnosis of heart failure (2003) (0)
- Cardiac troponin I predicts outcome in high risk open-heart surgery patients (1999) (0)
- Heart failure / cardiomyopathy Indications and practical approach to non-invasive ventilation in acute heart failure (2017) (0)
- Influence of Gender and Copeptin Levels on Clinical Outcomes in Patients With Acute Heart Failure (2016) (0)
- Renin Angiotensin Aldosterone System Inhibitors and Hyperkalemia in Acute Heart Failure (2019) (0)
- HF Assessment with BNP in the Home: Primary Results of the Mulitcenter HABIT Trial (2011) (0)
- HEART FAILURE PATIENTS WITH ELEVATED PRO-ENDOTHELIN HAVE IMPROVED MORTALITY ON STATIN THERAPY (2015) (0)
- Abstract P032: Adiponectin is Significantly Associated with NT-pro BNP Levels: The Multi-Ethnic Study of Atherosclerosis (2014) (0)
- IMPLICATIONS OF WORSENING RENAL FUNCTION BEFORE PRESENTATION FOR ACUTE HEART FAILURE (2022) (0)
- BIOMARKER MODEL FOR CORONARY ARTERY DISEASE (2016) (0)
- Algorithms for assessing cardiovascular risk in women. Authors' reply (2007) (0)
- NT-PROBNP PREDICTS THE DEVELOPMENT OF ARTERIAL HYPERTENSION IN NORMOTENSIVE AND PREHYPERTENSIVE SUBJECTS: THE MULTIETHNIC STUDY OF ATHEROSCLEROSIS (MESA) (2012) (0)
- HOW BNP AND BODY WEIGHT CHANGES VARY IN HEART FAILURE WITH PRESERVED EJECTION FRACTION COMPARED TO REDUCED EJECTION FRACTION: SECONDARY RESULTS OF THE HABIT (HF ASSESSMENT WITH BNP IN THE HOME) TRIAL (2014) (0)
- Natriuretic Peptide-guided Therapy for Heart Failure. (2022) (0)
- Diagnostic and Prognostic Biomarkers in Emergency Department Heart Failure (2012) (0)
- A Practical Approach for the Use of Biomarkers in Heart Failure (2020) (0)
- Elevated Discharge Copeptin is Highly Predictive of 90 Day Mortality in Acute Heart Failure Patients: Secondary Results from the Biomarkers in Acute Heart Failure (BACH) Trial (2012) (0)
- Faculty Opinions recommendation of The Interleukin-1 Axis and Risk of Death in Patients With Acutely Decompensated Heart Failure. (0)
- Mitigation of 1l- and/or P2-adrenoceptor function in human heart failure (2006) (0)
- Abstract 4037: Predictors of Elevated Troponin T in an Apparently Healthy Older Population: The Rancho Bernardo Study (2006) (0)
- The Role of Biomarkers in Heart Failure with Preserved Ejection Fraction (2022) (0)
- ValidationofPlasmaProneurotensinasaNovelBiomarker for the Prediction of Incident Breast Cancer (2014) (0)
- Is verapamil an inimunosuppressive drug in vivo (1990) (0)
- BIOMARKER CHANGES IN OBESE PATIENTS WITH ACUTE HEART FAILURE (2019) (0)
- Caveats Using Natriuretic Peptide Levels (2016) (0)
- 37: Acute Heart Failure Patients Needing Antibiotic Therapy Can Be Identified by Procalcitonin Measurements: Observational Results From the BACH Multinational Trial (2010) (0)
- RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM BLOCKADE THERAPY IS ASSOCIATED WITH IMPROVED MORTALITY WHEN ECHOCARDIOGRAPHIC EVIDENCE OF DIASTOLIC DYSFUNCTION IS PRESENT (2015) (0)
- Hyperkalemia, Worsening Renal Function, Acute Kidney Injury and Clinical Outcomes in Acute Heart Failure (2019) (0)
- Abstract 18075: Galectin-3 is Independently Associated with Cardiovascular Disease in Community-Dwelling Older Adults: The Rancho Bernardo Study (2012) (0)
- Chapter 35 Biomarkers in acute heart failure (2010) (0)
- Risk Stratification of Patients with Acute Coronary Syndrome and Congestive Heart Failure (2007) (0)
- Biomarkers in Cardio-Renal Dysfunction (2016) (0)
- 1049-109 Evaluation of B-type natriuretic peptide levels in normal and pre-eclamptic women during pregnancy (2004) (0)
- Epidemiology, PreventionPatients with Heart Failure Have Increased Prevalence of Aspirin Resistance: Preliminary Results from the ARTIST Trial (2006) (0)
- Using Natriuretic Peptides in the Emergency Department (2018) (0)
- Use of Natriuretic Peptides in Preparticipation Screening of College Varsity Athletes (2006) (0)
- Chapter-30 Management of the Patient with Heart Failure with Preserved Ejection Fraction (2014) (0)
- VOLUME OVERLOAD AT DISCHARGE MEASURED USING BIOELECTRICAL IMPEDANCE VECTOR ANALYSIS PREDICTS OUTCOME IN PATIENTS HOSPITALIZED WITH ACUTE DECOMPENSATED HEART FAILURE (2012) (0)
- ORAL ABSTRACT SESSION: CLINICAL (2013) (0)
- [Natriuretic peptides as prognosticators in congestive heart failure]. (2006) (0)
- Italian RED Study Sub-Analysis: 30-Day Post-Discharge BNP Levels Predict 6-Month All-Cause Mortality and Cardiac Events (2011) (0)
- Abstract 3476: Increased Prevalence of Aspirin Non-Responsiveness in Heart Failure Patients: Results from the Aspirin Resistance Testing and Initial Strategy for Treatment (ARTIST) Multicenter Trial (2007) (0)
- Abstract 3390: The Value of Soluble ST2 Measurement for the Diagnostic and Prognostic Evaluation of Patients with Acute Dyspnea (2006) (0)
- Faculty Opinions recommendation of High-Sensitivity Troponin I and Incident Coronary Events, Stroke, Heart Failure Hospitalization, and Mortality in the ARIC Study. (0)
- SEX-SPECIFIC EFFECTS OF HEMODYNAMIC-GUIDED MANAGEMENT ON HEART FAILURE OUTCOMES: A POOLED ANALYSIS FROM THE CHAMPION AND GUIDE-HF TRIALS (2023) (0)
- Faculty Opinions recommendation of Prognostic Value of High-Sensitivity Troponin T in Chronic Heart Failure: An Individual Patient Data Meta-Analysis. (0)
- Abstract 16234: Galectin-3 Levels in Young Adults With a History of Kawasaki Disease (2013) (0)
- Reply to: Decision algorithms are needed in acute heart failure in the emergency department. (2013) (0)
- ASSOCIATION BETWEEN LARGE AND SMALL ARTERY ELASTICITY AND NT-PRO B-TYPE NATRIURETIC PEPTIDE: RESULTS OF THE MULTI-ETHNIC STUDY FOR ATHEROSCLEROSIS (2010) (0)
- 82PPLASMA PRONEUROTENSIN AS A NOVEL BIOMARKER FOR THE PREDICTION OF INCIDENT BREAST CANCER (2013) (0)
- Treatment Delay and Mortality across a Spectrum of Immunoreactive BNP Levels in Acute Decompensated Heart Failure: An ADHERE Analysis (2008) (0)
- MID REGIONAL PRO-ADRENOMEDULLIN (MR-PROADM) IS SUPERIOR TO BNP (B-TYPE NATRIURETIC PEPTIDE) IN PREDICTING MORTALITY IN STABLE OUTPATIENTS WITH STAGE A HEART FAILURE FOLLOWED FOR 6 YEARS (2011) (0)
- ARRHYTHMrl Complex ventricular arrhythmias in patients with Q wave versus non-Q wave myocardial infarction (2005) (0)
- Prognostic Value of MR-proADM and Troponin in Patients with Acute Dyspnea: The Biomarkers in Acute Heart Failure (BACH) Trial (2010) (0)
- Increased Mortality in Diabetic Patients With Elevated Copeptin Levels: Secondary Analysis of the Biomarkers in Acute Heart Failure (BACH) Trial (2012) (0)
- Minute Ventilation-Targeted Adaptive Servo Ventilation Reduces Kidney Injury In Patients With Acute Decompensated Heart Failure (2015) (0)
- Reply to Letter to the Editor: Minimally Elevated Cardiac Troponin T and Elevated N-terminal Pro B-type Natriuretic Peptide Predict Mortality in Older Adults: Results from the Rancho Bernardo Study (2009) (0)
- Abstract 3486: Minimally Elevated Cardiac Troponin T Independently Predicts Death in Apparently Healthy Adults: Results from the Rancho Bernardo Study (2007) (0)
- Post Traumatic Stress Disorder Is Associated with Increased Mortality in Stable Outpatients with Elevated B-Type Natriuretic Peptide (2011) (0)
- Abstract 2952: Utility of NT-proBNP and B-Type Natriuretic Peptide in Predicting 90 day Mortality of Hospitalized Patients with Congestive Heart Failure (2006) (0)
- Elevated Troponin Is Associated with Increased Mortality in Patients with Acute Dyspnea (2011) (0)
- COPEPTIN AS A SURROGATE FOR VOLUME STATUS AND SERIAL MONITORING IN HEART FAILURE (2015) (0)
- Hemodynamically-Guided Management of Heart Failure Across the Ejection Fraction Spectrum: The GUIDE-HF Trial. (2022) (0)
- New Marker of Heart Failure Outcomes: Galectin-3 (2020) (0)
- Cardiac Biomarkers in the Emergency Department : the role of sST 2 in acute heart failure and acute coronary syndrome-There is meat on the bone (2019) (0)
- 1049-108 B-type natriuretic peptide and chest radiograph findings as indicators of systolic dysfunction in patients presenting with acute dyspnea (2004) (0)
- Abstract 12359: Prognostic Utility of Plasma NGAL in Patients Admitted With Heart Failure-30 Day Results of the GALLANT Trial (2010) (0)
- 1156. Observation of Stethoscope Sanitation Practices in an Emergency Department Setting (2018) (0)
- Response by Horiuchi et al to Letter Regarding Article, "Biomarkers Enhance Discrimination and Prognosis of Type 2 Myocardial Infarction". (2021) (0)
- Total Body Water Measured with BIVA (Bioelectrical Impedance Vector Analysis) Predicts Outcome in Patients Hospitalized with Acute Heart Failure (2011) (0)
- Faculty Opinions recommendation of Clinical value of pre-discharge bio-adrenomedullin as a marker of residual congestion and high risk of heart failure hospital readmission. (0)
- Abstract 2213: Characteristics of Aspirin Non-Responders: Results from the Aspirin Resistance Testing and Initial Strategy for Treatment (ARTIST) Multicenter Trial (2007) (0)
- Review Article The Potential Role of Natriuretic PeptideeGuided Management for Patients Hospitalized for Heart Failure (2015) (0)
- Brain Natriuretic Peptide Helps Prognosticate Improvement in Renal Function in Acute Heart Failure (2018) (0)
- Implications for Congestive Heart Failure (2005) (0)
- 1049-112 Utility of B-type natriuretic peptide and ProBNP in evaluation of patients receiving natrecor therapy (UBET study) (2004) (0)
- ADAPT Trial Symptoms Using Contemporary Troponins as the Only Biomarker: The 2-Hour Accelerated Diagnostic Protocol to Assess Patients With Chest Pain (2012) (0)
- INCREMENTAL PREDICTIVE VALUE FOR INCIDENT CARDIOVASCULAR DISEASE OF 4 SUBCLINICAL MARKERS COMBINED: LIPOPROTEIN PARTICLE CONCENTRATION, NT-PROBNP CONCENTRATION, CORONARY ARTERY CALCIFICATION SCORE AND SMALL ARTERY STIFFNESS IN ASYMPTOMATIC SUBJECTS IN THE MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (2011) (0)
- Beneficial Effects ofMetoprolol Treatment in Congestive HeartFailure (1994) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Alan S. Maisel?
Alan S. Maisel is affiliated with the following schools:
